MBRX

Moleculin Biotech Inc
1.25
0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type
Moleculin Biotech Inc MBRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.25 09:20:10
Open Price Low Price High Price Close Price Prev Close
1.25
more quote information »

Recent News

Date Time Source Heading
2/03/202317:21EDGARCurrent Report Filing (8-k)
1/05/202308:45PRNUSMoleculin to Present at the Virtual Investor 2023 Companies..
12/21/202208:25PRNUSMoleculin Receives Approval in Italy to Conduct Phase 1/2..
12/15/202208:39EDGARCurrent Report Filing (8-k)
12/15/202208:35PRNUSMoleculin Reports 80% Overall Response Rate in Final Cohort..
12/07/202208:46EDGARCurrent Report Filing (8-k)
12/07/202208:45PRNUSMoleculin Granted FDA Fast Track Designation of WP1122 for..
11/23/202208:31EDGARStatement of Changes in Beneficial Ownership (4)
11/14/202208:01EDGARCurrent Report Filing (8-k)
11/12/202207:15TRMNMoleculin Biotech (MBRX) Receives a Buy from Maxim Group
11/10/202216:14EDGARCurrent Report Filing (8-k)
11/10/202216:08EDGARQuarterly Report (10-q)
11/10/202216:05PRNUSMoleculin Reports Third Quarter 2022 Financial Results and..
11/07/202209:05PRNUSMoleculin to Report Third Quarter 2022 Financial Results on..
10/14/202208:41EDGARCurrent Report Filing (8-k)
10/14/202208:40PRNUSMoleculin Provides Update on Second Multiple Ascending Dose..
9/27/202208:38EDGARCurrent Report Filing (8-k)
9/27/202208:35PRNUSMoleculin Biotech WP1122 Portfolio Compound, WP1096,..
9/23/202209:11PRNUSMoleculin Biotech to Present at the Virtual Investor..
9/09/202216:03EDGARCurrent Report Filing (8-k)
9/08/202208:45PRNUSMoleculin Selected to Present at the 2nd Annual Marie..
9/07/202208:35PRNUSMoleculin to Present at the H.C. Wainwright 24th Annual..
9/06/202208:46EDGARCurrent Report Filing (8-k)
9/06/202208:45PRNUSMoleculin Receives FDA Orphan Drug Designation of WP1122 for..
8/19/202208:40PRNUSMoleculin Announces Completion of Third Single Ascending..
8/18/202217:07EDGARCurrent Report Filing (8-k)
8/16/202212:25TRMNMaxim Group Keeps Their Buy Rating on Moleculin Biotech..
8/15/202208:49EDGARCurrent Report Filing (8-k)
8/15/202208:35PRNUSMoleculin Reports Second Quarter 2022 Financial Results and..
7/30/202208:45TRMNMaxim Group Keeps Their Buy Rating on Moleculin Biotech..
7/28/202208:36EDGARCurrent Report Filing (8-k)
7/28/202208:35PRNUSMoleculin Concludes Phase 1b and Opens Recruitment in Phase..
7/19/202217:18EDGARSecurities Registration: Employee Benefit Plan (s-8)
7/08/202208:38EDGARCurrent Report Filing (8-k)
7/08/202208:35PRNUSMoleculin Announces Completion of Second Single Ascending..
7/06/202218:02EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:05EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:05EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:05EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:05EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:04EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:03EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:03EDGARStatement of Changes in Beneficial Ownership (4)
6/22/202219:03EDGARStatement of Changes in Beneficial Ownership (4)
6/16/202208:37EDGARCurrent Report Filing (8-k)
6/16/202208:35PRNUSMoleculin Announces Completion of First Single Ascending..
6/09/202216:32EDGARCurrent Report Filing (8-k)
5/26/202208:35PRNUSMoleculin Commences Dosing in Healthy Volunteers in Phase 1a..
5/20/202216:37EDGARCurrent Report Filing (8-k)
5/19/202208:05PRNUSMoleculin to Present at the H.C. Wainwright Global..